Тёмный

BRCCH | Identifying Gut Microbiome Contributions to Drug Metabolism and Carcinogen Toxicity 

Basel Research Centre for Child Health
Подписаться 168
Просмотров 272
50% 1

Speaker: Michael Zimmermann is a group leader at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Michael received his Bachelor’s degree in Pharmaceutical Sciences from Basel University and his Master’s degree in Biotechnology from the Ecole Supérieure de Biotechnologie (ESBS) in Strasbourg. Michael performed his PhD work at ETH Zurich in metabolomics and Systems Biology and he pursued his postdoctoral training at Yale University to investigate metabolic host-microbiome interactions. His research group at EMBL employs bacterial genetics, metabolomics, gnotobiotic mouse work, and mathematical modeling to systematically map metabolic microbiota-host interactions. Among several honors and scholarships, Michael was awarded the Daimler Benz Scholarship, Agilent’s Steve Berger Award, the 2021 FEBS Anniversary Prize, and an ERC Starting Grant.
This seminar is within the theme "The Gut Microbiome as a Tool for Individualised Medicine" as part of the BRCCH 2023 seminar series.

Наука

Опубликовано:

 

15 ноя 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Keynote - Gut Microbiome: Myths and Metabolites
26:59
Просмотров 1,3 тыс.
ВОТ ЧТО МЫ КУПИЛИ НА ALIEXPRESS
09:35
Просмотров 746 тыс.
The Gut Microbiome with Chris Damman, MD, MA
1:21:35
Просмотров 21 тыс.
6 Levels of Thinking Every Student MUST Master
17:12
Просмотров 1,3 млн
80 Year Olds Share Advice for Younger Self
12:22
Просмотров 1,5 млн
Understanding CRISPR-Cas9
35:15
Просмотров 165 тыс.
Красиво, но телефон жаль
0:32
Просмотров 1,6 млн